Sinopharm to produce 5 billion doses per year with foreign partners: firm executives

BEIJING (Global Times): China's Sinopharm is expanding the production capacity to five billion doses per year with accelerating overseas cooperation after one of its Covid-19 vaccines was included in the Emergency Using List of the World Health Organisation (WHO), company executives said at a forum on Thursday (May 13) in Shanghai.

Sinopharm has produced more than 400 million doses of Covid-19 vaccines and more than 200 million doses have been supplied at home and abroad, Sinopharm executives said.